We are live on ! Find out more
Citadel Advisors

Citadel Advisors Portfolio holdings

AUM $618B
1-Year Est. Return 30.34%
 

Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.

This Fund
S&P 500
This Quarter Est. Return
-1.06%
1 Year Est. Return
+30.34%
3 Year Est. Return
+94.87%
5 Year Est. Return
+105.94%
10 Year Est. Return
+433.28%
AUM
$481B
AUM Growth
+$34.6B
Cap. Flow
+$38.1B
Cap. Flow %
7.92%
Top 10 Hldgs %
29.35%
Holding
15,428
New
1,884
Increased
5,796
Reduced
5,769
Closed
1,724

Top Buys

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$1.26B
2
MSFT icon
Microsoft
MSFT
+$633M
3
BABA icon
Alibaba
BABA
+$501M
4
ATVI
Activision Blizzard
ATVI
+$484M
5
AAPL icon
Apple
AAPL
+$456M

Sector Composition

Rank Sector Weight
1 Technology 3.03%
2 Consumer Discretionary 2.25%
3 Healthcare 2.2%
4 Financials 2.18%
5 Industrials 1.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SVRA icon
13551
PUT
Savara
SVRA
$1.12B
$17K ﹤0.01%
12,200
-20,800
-63% -$28.1K
UTSI icon
13552
UTStarcom
UTSI
$23.5M
$17K ﹤0.01%
3,629
-495
-12% -$2.62K
CSCI
13553
PUT
DELISTED
COSCIENS Biopharma Inc. Common Stock
CSCI
$17K ﹤0.01%
229
-127
-36% -$9.02K
CSLT
13554
PUT
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$17K ﹤0.01%
10,800
-12,600
-54% -$24.7K
FURY
13555
Fury Gold Mines
FURY
$102M
$16K ﹤0.01%
+25,399
New +$22K
BTMDW
13556
DELISTED
Biote Corp. Warrant
BTMDW
$16K ﹤0.01%
+20,509
New +$18.3K
NBRV
13557
PUT
DELISTED
Nabriva Therapeutics plc Ordinary Shares Ireland
NBRV
$16K ﹤0.01%
532
-304
-36% -$8.58K
ATHE
13558
Alterity Therapeutics
ATHE
$80.1M
$15K ﹤0.01%
1,176
-2,622
-69% -$36.5K
SRGA
13559
CALL
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$15K ﹤0.01%
457
-1,880
-80% -$68.8K
ITP icon
13560
IT Tech Packaging
ITP
$2.97M
$14K ﹤0.01%
3,546
-18,527
-84% -$77.7K
ARYD
13561
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$14K ﹤0.01%
+1,412
New +$14.3K
OCAXW
13562
DELISTED
OCA Acquisition Corp. Warrant
OCAXW
$14K ﹤0.01%
26,007
+6,897
+36% +$4.04K
RAVE icon
13563
CALL
RAVE Restaurant Group
RAVE
$44.8M
$13K ﹤0.01%
+10,100
New +$13.2K
RAVE icon
13564
PUT
RAVE Restaurant Group
RAVE
$44.8M
$13K ﹤0.01%
10,000
-1,700
-15% -$2.22K
BYU
13565
DELISTED
BAIYU Holdings, Inc. Common Stock
BYU
$13K ﹤0.01%
74
-194
-72% -$39.1K
AGILW
13566
DELISTED
AgileThought Inc Warrant
AGILW
$13K ﹤0.01%
+12,834
New +$17.2K
LDHAW
13567
DELISTED
LDH Growth Corp I Warrant
LDHAW
$13K ﹤0.01%
+17,497
New +$17.8K
LJAQW
13568
DELISTED
LightJump Acquisition Corporation Warrant
LJAQW
$13K ﹤0.01%
24,296
OTRAW
13569
DELISTED
OTR Acquisition Corp. Warrant
OTRAW
$13K ﹤0.01%
24,845
ABVEW
13570
DELISTED
Above Food Ingredients Inc Warrants
ABVEW
$12K ﹤0.01%
+21,846
New +$14.3K
EVOJW
13571
DELISTED
Evo Acquisition Corp. Warrant
EVOJW
$12K ﹤0.01%
+22,291
New +$14.4K
QTT
13572
CALL
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$12K ﹤0.01%
1,210
-330
-21% -$4.74K
PTE
13573
CALL
DELISTED
PolarityTE, Inc. Common Stock
PTE
$12K ﹤0.01%
764
+268
+54% +$5.19K
SXTC icon
13574
China SXT Pharmaceuticals
SXTC
$2.36M
0
REED
13575
CALL
DELISTED
Reeds, Inc. Common Stock
REED
$11K ﹤0.01%
358
+110
+44% +$4.11K

Similar funds

Citadel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Citadel Advisors held 15,428 positions worth $481B, up 7.8% from $447B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Citadel Advisors deployed $38.1B of net new capital in Q3 2021, opening 1,884 new positions and adding to 5,796 existing holdings. Its largest new stake was Etsy: 948,509 shares worth $197M.

By sector, the portfolio is most concentrated in Technology at 3% of assets, down from 3% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $622M trimmed.

  • Citadel Advisors's largest Q3 2021 buy was Etsy: 948,509 shares worth $197M.
  • Citadel Advisors added most to Tesla in Q3 2021, an estimated $1.26B increase.
  • Citadel Advisors's biggest Q3 2021 reduction was Meta Platforms (Facebook), cutting an estimated $622M.
  • Citadel Advisors fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $597M.
  • Citadel Advisors's ten largest holdings make up 29% of its $481B portfolio in Q3 2021.
  • Citadel Advisors opened 1,884 new positions and closed 1,724 in Q3 2021.
  • Citadel Advisors's portfolio value rose 7.8% quarter-over-quarter to $481B.

Based on Citadel Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.